Report Overview

Asia Pacific Veterinary Vaccines Market – Industry Trends & Forecast Report, 2030

Asia Pacific Veterinary Vaccines Market size by value was estimated at USD 2.52 billion in 2023. During the forecast period between 2024 and 2030, the Asia Pacific Veterinary Vaccines Market size is expected to expand at a CAGR of 8.42% reaching a value of USD 4.01 billion by 2030. The Asia Pacific Veterinary Vaccines Market is primarily driven by the increasing prevalence of zoonotic diseases and the rising awareness about animal health and welfare. As livestock and pet populations grow, the need for effective vaccination programs becomes crucial to prevent the outbreak of infectious diseases that can devastate animal populations and impact human health through zoonotic transmission. Governments and international organizations are implementing stringent regulations and promoting vaccination programs to control and eradicate diseases such as rabies, foot-and-mouth disease, and avian influenza. The regulatory support, coupled with growing public awareness, is significantly boosting the demand for veterinary vaccines in the region.

By volume, the Asia Pacific Veterinary Vaccines Market size was estimated at 5.6 million doses in 2023. During the forecast period between 2024 and 2030, the Asia Pacific Veterinary Vaccines Market size is projected to grow at a CAGR of 7.89% reaching a volume of 7.2 million doses by 2030. Advancements in biotechnology and vaccine development are propelling the market forward. Innovations in vaccine technology, including the development of DNA vaccines, recombinant vaccines, and vector-based vaccines, are enhancing the efficacy and safety of veterinary vaccines. These technological advancements are supported by increased investments in research and development by both public and private sectors. Further, the expanding veterinary pharmaceuticals industry, along with improved infrastructure for animal healthcare, is facilitating better distribution and accessibility of vaccines. The synergistic effect of these factors is fostering a robust growth trajectory for the Asia Pacific veterinary vaccines market.

Veterinary Vaccines – Overview

Veterinary vaccines are biological preparations that provide immunity against infectious diseases in animals. They are crucial for preventing disease outbreaks, ensuring animal health, enhancing food security, and promoting animal welfare. These vaccines work by stimulating an animal's immune system to recognize and combat pathogens. They are used in pets, livestock, and wildlife, addressing diseases such as rabies, distemper, foot-and-mouth disease, and avian influenza. Advances in veterinary vaccinology include the development of recombinant and DNA vaccines, improving efficacy and safety. Overall, veterinary vaccines play a vital role in both animal and public health by controlling zoonotic diseases.

Asia Pacific Veterinary Vaccines Market

Growth Drivers

Increasing Prevalence of Zoonotic Diseases

The Asia Pacific Veterinary Vaccines Market is experiencing significant growth driven by the rising prevalence of zoonotic diseases. As urbanization and human-animal interactions intensify, the transmission of diseases, such as avian influenza, rabies, and leptospirosis is becoming more frequent. The surge in zoonotic outbreaks has heightened the demand for effective veterinary vaccines to safeguard animal health and prevent cross-species disease transmission. Additionally, growing awareness among pet owners and livestock farmers about the benefits of vaccination is bolstering market expansion. Consequently, governments and health organizations are investing more in veterinary healthcare infrastructure, further propelling market growth.

Challenges

High Storage Cost of Veterinary Vaccines

Asia Pacific Veterinary Vaccines Market faces significant challenges due to the high storage costs of vaccines. Veterinary vaccines require strict temperature-controlled environments to maintain efficacy, demanding specialized refrigeration units and constant monitoring. These storage requirements elevate operational expenses and also pose logistical hurdles, particularly in remote or underserved regions. Consequently, the financial burden of maintaining vaccine quality can limit market growth, restrict distribution, and increase the final cost for end-users, ultimately impacting the overall accessibility and adoption of veterinary vaccines across the region.

Impact of Escalating Geopolitical Tensions on Asia Pacific Veterinary Vaccines Market

Escalating geopolitical tensions in the Asia Pacific region significantly impacts the veterinary vaccines market. Trade disruptions due to conflicts, such as the US-China trade war, can lead to supply chain disruptions, increasing production costs and delaying vaccine availability. Border disputes, like those between India and China, strain cross-border trade and cooperation, hindering market growth. Additionally, political instability in regions like Hong Kong and Taiwan creates uncertainty, discouraging investment and innovation in the veterinary sector. For instance, export restrictions imposed by countries involved in tensions may limit the availability of essential raw materials and finished vaccines. Consequently, these factors collectively pose challenges to the steady growth and reliability of the Asia Pacific Veterinary Vaccines Market.

Asia Pacific Veterinary Vaccines Market

Segmental Coverage

Asia Pacific Veterinary Vaccines Market – By Vaccine Type

Based on vaccine type, Asia Pacific Veterinary Vaccines Market is divided into Poultry Vaccines, Livestock Vaccines (Bovine Vaccines, Small Ruminant Vaccines), Companion Animal Vaccines (Feline Vaccines, Canine Vaccines), and Aquaculture Vaccines segments. The livestock vaccines segment is the largest vaccine type in the Asia Pacific Veterinary Vaccines Market, driven by the high demand for bovine vaccines. The dominance is attributed to the significant livestock population and the increasing prevalence of livestock diseases, which necessitate effective vaccination programs. Bovine vaccines are particularly crucial due to the economic importance of cattle in the region, including dairy and meat production. The rising awareness among farmers about animal health and the support from government initiatives also contribute to the substantial market share of livestock vaccines in the Asia Pacific region.

Asia Pacific Veterinary Vaccines Market – By Technology

Based on technology, Asia Pacific Veterinary Vaccines Market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Conjugate Vaccines segments. The live attenuated vaccines segment is the leading technology in the Asia Pacific Veterinary Vaccines Market. Live attenuated vaccines are widely preferred due to their ability to induce strong and lasting immunity with fewer doses. These vaccines mimic natural infections, prompting robust immune responses. Additionally, their cost-effectiveness and efficiency in preventing various infectious diseases in animals contribute to their dominance in the market.

Asia Pacific Veterinary Vaccines Market – By Disease

Based on disease, Asia Pacific Veterinary Vaccines Market is divided into Porcine Disease, Poultry Disease, Livestock Disease, and Companion Animal Disease segments. The poultry disease is the largest segment in the Asia Pacific Veterinary Vaccines Market. The dominance is attributed to the significant demand for poultry products in the region, necessitating extensive vaccination programs to maintain flock health and productivity. The high prevalence of infectious diseases in poultry and advancements in vaccine technology further drive the segment's growth. Increasing awareness about animal health and government initiatives supporting vaccination campaigns also contribute to the prominence of the poultry disease segment in the Asia Pacific Veterinary Vaccines Market.

Asia Pacific Veterinary Vaccines Market – By Country

Based on country, Asia Pacific Veterinary Vaccines Market is divided into China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, and Rest of APAC. China is the leading country in the Asia Pacific Veterinary Vaccines Market, owing to its vast population and substantial agricultural sector. China's robust demand for veterinary vaccines stems from its extensive livestock industry and increasing awareness about animal health. The country's sheer size and economic influence contribute significantly to its dominance in the market segment. Additionally, China's proactive approach towards animal disease control and prevention further fuels the demand for veterinary vaccines, solidifying its position as the leading segment in the Asia Pacific region.

Competitive Landscape

Major players in the Asia Pacific Veterinary Vaccines Market include Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco, Hester Biosciences Ltd, HIPRA, Merck & Co., Virbac, China Animal Husbandry Industry Co., Ltd, Tianjin Ringpu Bio-Technology Co., Ltd, Jinyu Biotechnology Co., Ltd, and Zoetis Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In June 2022 – Narendra Singh Tomar, the Union Minister of Agriculture & Farmers' Welfare, launched Animal Vaccine and other Diagnostic Kits developed by the ICAR-National Research Centre on Equines in Hisar, Haryana, India.

Scope of the Report

By Vaccine Type

• Poultry Vaccine

• Livestock Vaccines

  • 1. Bovine Vaccines

    2. Small Ruminant Vaccines

• Companion Animal Vaccines

  • 1. Feline Vaccines

    2. Canine Vaccines

• Aquaculture Vaccine

By Technology

• Live Attenuated Vaccines

• Inactivated Vaccines

• Toxoid Vaccines

• Recombinant Vaccines

• Conjugate Vaccines

By Disease

• Porcine Disease

• Poultry Disease

• Livestock Disease

• Companion Animal Disease

By Country

• China

• India

• Japan

• South Korea

• Australia & New Zealand

• Indonesia

• Malaysia

• Singapore

• Vietnam

• Rest of APAC

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3.  Asia Pacific Veterinary Vaccines Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising demand for animal-derived food products
         2. Growing awareness of animal health
         3. Increasing prevalence of zoonotic diseases
         4. Expansion of key players in emerging markets
      2. Restraints
         1. High storage cost of veterinary vaccines
         2. Stringent government regulations
         3. Limited skilled labor
         4. High development costs
      3. Opportunities
         1. Growing companion animal population
         2. Rising awareness through digital campaigns
         3. Government initiatives for animal health
      4. Challenges
         1. Limited access to vaccines in rural areas
         2. High prices of veterinary vaccines
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. Asia Pacific Veterinary Vaccines Market: Marketing Strategies
5. Asia Pacific Veterinary Vaccines Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share and Forecast
      1. By Vaccine Type
         1. Poultry Vaccine
         2. Livestock Vaccines
            1. Bovine Vaccines
         3.           Small Ruminant Vaccines
         4. Companion Animal Vaccines
            1. Feline Vaccines
            2. Canine Vaccines
            3. Others
         5. Aquaculture Vaccine
         6. Others
      2. By Technology
         1. Live Attenuated Vaccines
         2. Inactivated Vaccines
         3. Toxoid Vaccines
         4. Recombinant Vaccines
         5. Conjugate Vaccines
         6. Others
      3. By Disease
         1. Porcine Disease
         2. Poultry Disease
         3. Livestock Disease
         4. Companion Animal Disease
         5. Others
      4. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Australia & New Zealand
         6. Indonesia
         7. Malaysia
         8. Singapore
         9. Vietnam
         10. Rest of APAC
6. China Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Vaccine Type
      2. By Technology
      3. By Disease
7. India Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Vaccine Type
      2. By Technology
      3. By Disease
8. Japan Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Vaccine Type
      2. By Technology
      3. By Disease
9. South Korea Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Vaccine Type
      2. By Technology
      3. By Disease
10. Australia & New Zealand Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Vaccine Type
       2. By Technology
       3. By Disease
11. Indonesia Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Vaccine Type
       2. By Technology
       3. By Disease
12. Malaysia Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Vaccine Type
       2. By Technology
       3. By Disease
13. Singapore Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Vaccine Type
       2. By Technology
       3. By Disease
14. Vietnam Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Vaccine Type
       2. By Technology
       3. By Disease
15. Rest of APAC Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Vaccine Type
       2. By Technology
       3. By Disease
16. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Asia Pacific Veterinary Vaccines Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
17. Impact of Escalating Geopolitical Tensions on Asia Pacific Veterinary Vaccines Market
18. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Boehringer Ingelheim International GmbH
    2. Ceva Sante Animale
    3. Elanco
    4. Hester Biosciences Ltd
    5. HIPRA
    6. Merck & Co.
    7. Virbac
    8. China Animal Husbandry Industry Co., Ltd
    9. Tianjin Ringpu Bio-Technology Co., Ltd
    10. Jinyu Biotechnology Co., Ltd
    11. Zoetis Inc.
    12. Other Prominent Players
19. Key Strategic Recommendations
20. Research Methodology
    1.    Qualitative Research
       1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
       1.  Secondary Research
       2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Country
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       Asia Pacific Veterinary Vaccines Segmentation

Figure 2       Asia Pacific Veterinary Vaccines Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Asia Pacific Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 5       Asia Pacific Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 6       Asia Pacific Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 7       Asia Pacific Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 8       Asia Pacific Veterinary Vaccines Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 9       Asia Pacific Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 10     Asia Pacific Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 11     Asia Pacific Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 12     Asia Pacific Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 13     Asia Pacific Veterinary Vaccines Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 14     China Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 15     China Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 16     China Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 17     China Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 18     India Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 19     India Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 20     India Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 21     India Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 22     Japan Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 23     Japan Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 24     Japan Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 25     Japan Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 26     South Korea Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 27     South Korea Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 28     South Korea Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 29     South Korea Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 30     Australia & New Zealand Veterinary Vaccines Market Size, By Value ((USD Billion), 2019–2030

Figure 31     Australia & New Zealand Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 32     Australia & New Zealand Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 33     Australia & New Zealand Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 34     Indonesia Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 35     Indonesia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 36     Indonesia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 37     Indonesia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 38     Malaysia Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 39     Malaysia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 40     Malaysia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 41     Malaysia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 42     Singapore Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 43     Singapore Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 44     Singapore Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 45     Singapore Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 46     Vietnam Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 47     Vietnam Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 48     Vietnam Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 49     Vietnam Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Figure 50     Rest of APAC Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Figure 51     Rest of APAC Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Figure 52     Rest of APAC Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Figure 53     Rest of APAC Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

List of Tables

Table 1 Asia Pacific Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 2 Asia Pacific Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 3 Asia Pacific Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 4 Asia Pacific Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 5 Asia Pacific Veterinary Vaccines Market Share, By Country, By Value (USD Billion), 2019–2030

Table 6 China Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 7        China Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 8        China Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 9 China Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 10      India Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 11      India Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 12      India Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 13      India Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 14      Japan Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 15      Japan Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 16      Japan Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 17      Japan Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 18      South Korea Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 19      South Korea Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 20      South Korea Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 21      South Korea Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 22      Australia & New Zealand Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 23      Australia & New Zealand Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 24      Australia & New Zealand Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 25      Australia & New Zealand Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 26      Indonesia Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 27      Indonesia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 28      Indonesia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 29      Indonesia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 30      Malaysia Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 31      Malaysia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 32      Malaysia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 33      Malaysia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 34      Singapore Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 35      Singapore Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 36      Singapore Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 37      Singapore Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 38      Vietnam Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 39      Vietnam Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 40      Vietnam Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 41      Vietnam Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 42      Rest of APAC Veterinary Vaccines Market Size, By Value (USD Billion), 2019–2030

Table 43      Rest of APAC Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019–2030

Table 44      Rest of APAC Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019–2030

Table 45      Rest of APAC Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019–2030

Table 46      Boehringer Ingelheim International GmbH Company Overview

Table 47      Boehringer Ingelheim International GmbH Financial Overview

Table 48      Ceva Sante Animale Company Overview

Table 49      Ceva Sante Animale Financial Overview

Table 50      Elanco Company Overview

Table 51      Elanco Financial Overview

Table 52      Hester Biosciences Ltd Company Overview

Table 53      Hester Biosciences Ltd Financial Overview

Table 54      HIPRA Company Overview

Table 55      HIPRA Financial Overview

Table 56      Merck & Co. Company Overview

Table 57      Merck & Co. Financial Overview

Table 58      Virbac Company Overview

Table 59      Virbac Financial Overview

Table 60      China Animal Husbandry Industry Co., Ltd Company Overview

Table 61      China Animal Husbandry Industry Co., Ltd Financial Overview

Table 62      Tianjin Ringpu Bio-Technology Co., Ltd Company Overview

Table 63      Tianjin Ringpu Bio-Technology Co., Ltd Financial Overview

Table 64      Jinyu Biotechnology Co., Ltd Company Overview

Table 65      Jinyu Biotechnology Co., Ltd Financial Overview

Table 66      Zoetis Inc. Company Overview

Table 67      Zoetis Inc. Financial Overview